Shander Aryeh, Goodnough Lawrence Tim
Department of Anesthesiology, Critical Care and Hyperbaric Medicine, Englewood Hospital and Medical Center, Englewood, NJ 07631, USA.
Crit Care Clin. 2009 Apr;25(2):261-77, Table of Contents. doi: 10.1016/j.ccc.2008.12.012.
Allogeneic blood transfusions have been associated with several risks and complications and with worse outcomes in a substantial number of patient populations and clinical scenarios. Allogeneic blood is costly and difficult to procure, transport, and store. Global and local shortages are imminent. Alternatives to transfusion provide many advantages, and their use is likely to improve outcomes as safer and more effective agents are developed.
异体输血与多种风险和并发症相关，并且在大量患者群体和临床情况下会导致更差的结果。异体血成本高昂，采购、运输和储存都很困难。全球和局部短缺即将出现。输血替代方法具有诸多优势，随着更安全、更有效的药物的研发，使用这些替代方法可能会改善治疗结果。
